{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T23:30:43Z","timestamp":1789947043257,"version":"4.0.1"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1097\/md.0000000000002803","type":"journal-article","created":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T11:37:32Z","timestamp":1457005052000},"page":"e2803","source":"Crossref","is-referenced-by-count":25,"title":["Prognostic Value of KIF2A and HER2-Neu Overexpression in Patients With Epithelial Ovarian Cancer"],"prefix":"10.1097","volume":"95","author":[{"given":"Di","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunzhao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-27-20210309","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejogrb.2011.04.023","article-title":"An overview of biomarkers for the ovarian cancer diagnosis.","volume":"158","author":"Zhang","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R2-27-20210309","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1158\/1078-0432.CCR-09-2642","article-title":"Frequent downregulation of miR-34 family in human ovarian cancers.","volume":"16","author":"Corney","year":"2010","journal-title":"Clin Cancer Res"},{"key":"R3-27-20210309","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1158\/1535-7163.MCT-10-0239","article-title":"Targeted therapies for non-small cell lung cancer: an evolving landscape.","volume":"9","author":"Pal","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"R4-27-20210309","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/JTO.0b013e3181758141","article-title":"Biological agents in non-small cell lung cancer: a review of recent advances and clinical results with a focus on epidermal growth factor receptor and vascular endothelial growth factor.","volume":"3","author":"Kelly","year":"2008","journal-title":"J Thorac Oncol"},{"key":"R5-27-20210309","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1158\/1078-0432.CCR-11-2017","article-title":"Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnostics.","volume":"18","author":"Parkinson","year":"2012","journal-title":"Clin Cancer Res"},{"key":"R6-27-20210309","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.oraloncology.2009.11.003","article-title":"Overexpression of Kif2a promotes the progression and metastasis of squamous cell carcinoma of the oral tongue.","volume":"46","author":"Wang","year":"2010","journal-title":"Oral Oncol"},{"key":"R7-27-20210309","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3892\/mmr.2013.1804","article-title":"Silencing Kif2a induces apoptosis in squamous cell carcinoma of the oral tongue through inhibition of the PI3KAkt signaling pathway.","volume":"9","author":"Wang","year":"2014","journal-title":"Mol Med Rep"},{"key":"R8-27-20210309","doi-asserted-by":"crossref","first-page":"e49829","DOI":"10.1371\/journal.pone.0049829","article-title":"Primary human ovarian epithelial cancer cells broadly express HER2 at immunologically-detectable levels.","volume":"7","author":"Lanitis","year":"2012","journal-title":"PLoS ONE"},{"key":"R9-27-20210309","first-page":"51","article-title":"PI3KAKTmTOR pathway inhibitors: the ideal combination partners for breast cancer therapies Expert Rev Anticancer T","volume":"15","author":"Abraham","year":"2015","journal-title":"her"},{"key":"R10-27-20210309","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1093\/annonc\/mdn169","article-title":"HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target.","volume":"19","author":"Gravalos","year":"2008","journal-title":"Ann Oncol"},{"key":"R11-27-20210309","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/gutjnl-2011-301839","article-title":"A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets.","volume":"61","author":"Deng","year":"2012","journal-title":"Gut"},{"key":"R12-27-20210309","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2165\/00063030-200721020-00001","article-title":"HER-2-positive breast cancer: hope beyond trastuzumab.","volume":"21","author":"Bartsch","year":"2007","journal-title":"BioDrugs"},{"key":"R13-27-20210309","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1007\/s12032-011-0152-1","article-title":"High expression of CXCR2 is associated with tumorigenesis, progression, and prognosis of laryngeal squamous cell carcinoma.","volume":"29","author":"Han","year":"2012","journal-title":"Med Oncol"},{"key":"R14-27-20210309","doi-asserted-by":"crossref","first-page":"8895","DOI":"10.1007\/s13277-015-3603-z","article-title":"KIF2A overexpression and its association with clinicopathologic characteristics and unfavorable prognosis in colorectal cancer.","volume":"36","author":"Fan","year":"2015","journal-title":"Tumour Biol"},{"key":"R15-27-20210309","doi-asserted-by":"crossref","first-page":"12104","DOI":"10.1038\/srep12104","article-title":"Overexpression of MAGE-A9 is predictive of poor prognosis in epithelial ovarian cancer.","volume":"5","author":"Xu","year":"2015","journal-title":"Sci Rep"},{"key":"R16-27-20210309","doi-asserted-by":"crossref","first-page":"12398","DOI":"10.18632\/oncotarget.2643","article-title":"Prognostic value of LAMP3 and TP53 overexpression in benign and malignant gastrointestinal tissues.","volume":"5","author":"Sun","year":"2014","journal-title":"Oncotarget"},{"key":"R17-27-20210309","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","article-title":"X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization.","volume":"10","author":"Camp","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R18-27-20210309","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1186\/1471-2407-14-461","article-title":"KIF2A silencing inhibits the proliferation and migration of breast cancer cells and correlates with unfavorable prognosis in breast cancer.","volume":"14","author":"Wang","year":"2014","journal-title":"BMC Cancer"},{"key":"R20-27-20210309","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1091\/mbc.e07-02-0110","article-title":"The Kinesin-13 proteins Kif2a, Kif2b, and Kif2cMCAK have distinct roles during mitosis in human cells.","volume":"18","author":"Manning","year":"2007","journal-title":"Mol Biol Cell"},{"key":"R21-27-20210309","doi-asserted-by":"crossref","first-page":"E28","DOI":"10.1038\/35050669","article-title":"The spindle: a dynamic assembly of microtubules and motors.","volume":"3","author":"Wittmann","year":"2001","journal-title":"Nat Cell Biol"},{"key":"R22-27-20210309","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1349-7006.2007.00635.x","article-title":"Involvement of Kinesin family member 2Cmitotic centromere-associated Kinesin overexpression in mammary carcinogenesis.","volume":"99","author":"Shimo","year":"2008","journal-title":"Cancer Sci"},{"key":"R23-27-20210309","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1158\/0008-5472.CAN-04-3613","article-title":"Centromere protein H is up-regulated in primary human colorectal cancer and its overexpression induces aneuploidy.","volume":"65","author":"Tomonaga","year":"2005","journal-title":"Cancer Res"},{"key":"R24-27-20210309","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1038\/sj.bjc.6604379","article-title":"Mitotic centromere-associated Kinesin is a novel marker for prognosis and lymph node metastasis in colorectal cancer.","volume":"98","author":"Ishikawa","year":"2008","journal-title":"Br J Cancer"},{"key":"R25-27-20210309","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.cellbio.13.1.745","article-title":"The design plan of Kinesin motors.","volume":"13","author":"Vale","year":"1997","journal-title":"Annu Rev Cell Dev Biol"},{"key":"R26-27-20210309","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0955-0674(98)80087-2","article-title":"Kinesin and dynein superfamily proteins in organelle transport and cell division.","volume":"10","author":"Hirokawa","year":"1998","journal-title":"Curr Opin Cell Biol"},{"key":"R27-27-20210309","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/35024000","article-title":"Microtubule motors in mitosis.","volume":"407","author":"Sharp","year":"2000","journal-title":"Nature"},{"key":"R28-27-20210309","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1083\/jcb.200404012","article-title":"The KinI kinesin Kif2a is required for bipolar spindle assembly through a functional relationship with MCAK.","volume":"166","author":"Ganem","year":"2004","journal-title":"J Cell Biol"},{"key":"R29-27-20210309","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0092-8674(03)00522-1","article-title":"Kinesin superfamily protein 2A (KIF2A) functions in suppression of collateral branch extension.","volume":"114","author":"Homma","year":"2003","journal-title":"Cell"},{"key":"R30-27-20210309","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1073\/pnas.1107808109","article-title":"Phosphatidylinositol 4-phosphate 5-kinase alpha (PIPKalpha) regulates neuronal microtubule depolymerase Kinesin, KIF2A and suppresses elongation of axon branches.","volume":"109","author":"Noda","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"R31-27-20210309","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.cub.2005.08.065","article-title":"Efficient mitosis in human cells lacking poleward microtubule flux.","volume":"15","author":"Ganem","year":"2005","journal-title":"Curr Biol"},{"key":"R32-27-20210309","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1177\/030089160409000102","article-title":"Phosphoinositide 3-kinase signalling pathways in tumor progression, invasion and angiogenesis.","volume":"90","author":"Brader","year":"2004","journal-title":"Tumori"},{"key":"R33-27-20210309","first-page":"871","article-title":"Genotypic analysis of esophageal squamous cell carcinoma by molecular cytogenetics and real-time quantitative polymerase chain reaction.","volume":"23","author":"Yen","year":"2003","journal-title":"Int J Oncol"},{"key":"R34-27-20210309","doi-asserted-by":"crossref","first-page":"5918","DOI":"10.1158\/0008-5472.CAN-08-4623","article-title":"Progressive tumor formation in mice with conditional deletion of TGF-beta signaling in head and neck epithelia is associated with activation of the PI3KAkt pathway.","volume":"69","author":"Bian","year":"2009","journal-title":"Cancer Res"},{"key":"R35-27-20210309","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrd2926","article-title":"Targeting the phosphoinositide 3-kinase pathway in cancer.","volume":"8","author":"Liu","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"R36-27-20210309","doi-asserted-by":"crossref","first-page":"10781","DOI":"10.1074\/jbc.M500084200","article-title":"Nicotine inactivation of the proapoptotic function of Bax through phosphorylation.","volume":"280","author":"Xin","year":"2005","journal-title":"J Biol Chem"},{"key":"R37-27-20210309","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.2165\/00003495-200767090-00006","article-title":"HER2-positive breast cancer: current and future treatment strategies.","volume":"67","author":"Engel","year":"2007","journal-title":"Drugs"},{"key":"R38-27-20210309","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.1200\/JCO.2010.34.4879","article-title":"Phosphatidylinositol 3-kinase and antiestrogen resistance in breast cancer.","volume":"29","author":"Miller","year":"2011","journal-title":"J Clin Oncol"},{"key":"R39-27-20210309","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJMc1214189","article-title":"Aspirin, PIK3CA mutation, and colorectal-cancer survival.","volume":"368","author":"Sahin","year":"2013","journal-title":"N Engl J Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000002803","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T19:09:56Z","timestamp":1718392196000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201602230-00027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000002803","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]}}}